Cumulative expression of HIF-1-alpha, Bax, Bcl-xL and P53 in human colorectal cancer

Pathology

Volumn 39, Issue 3, 2007, Pages 334-338

  Wincewicz, Andrzei ^a   Sulkowska, Mariola ^a   Koda, Mariusz ^a   Sulkowski, Stanislaw ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Apoptosis; Bax; Bcl xL; Colorectal cancer; HIF 1 ; P53

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1ALPHA; PROTEIN BAX; PROTEIN BCL XL; PROTEIN P53;

ADENOCARCINOMA; ADULT; ARTICLE; COLON CANCER; COLORECTAL CANCER; CONTROLLED STUDY; CORRELATION COEFFICIENT; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTESTINE WALL; MAJOR CLINICAL STUDY; MALE; MUCINOUS CARCINOMA; PROTEIN ANALYSIS; PROTEIN DETERMINATION; PROTEIN EXPRESSION; RECTUM CANCER; SEX DIFFERENCE;

BCL-2-ASSOCIATED X PROTEIN; BCL-X PROTEIN; COLORECTAL NEOPLASMS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; IMMUNOHISTOCHEMISTRY; TUMOR SUPPRESSOR PROTEIN P53;

EID: 34250222046     PISSN: 00313025     EISSN: 14653931     Source Type: Journal    
DOI: 10.1080/00313020701329765     Document Type: Article

References (32)

1. Wang GL, Semenza GL. Purification and characterization of hypoxia-inducible factor 1. J Biol Chem 1995; 270: 1230-7.
2. Wang GL, Jiang BH, Rue EA, et al. Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc Natl Acad Sci USA 1995; 92: 5510-4.
3. Wood SM, Wiesener MS, Yeates KM, et al. Selection and analysis of a mutant cell line defective in the hypoxia-inducible factor-1 alpha-subunit (HIF-1alpha). Characterization of hif-1alpha-dependent and -independent hypoxia-inducible gene expression. J Biol Chem 1998; 273: 8360-8.
4. Lee JW, Bae SH, Jeong JW, et al. Hypoxia-inducible factor (HIF-1)alpha: its protein stability and biological functions. Exp Mol Med 2004; 36: 1-12.
5. Sowter HM, Ratcliffe PJ, Watson P, et al. HIF-1-dependent regulation of hypoxic induction of the cell death factors BNIP3 and NIX in human tumors. Cancer Res 2001; 61: 6669-73.
6. Koukourakis MI, Giatromanolaki A, Polychronidis A, et al. Endogenous markers of hypoxia/anaerobic metabolism and anemia in primary colorectal cancer. Cancer Sci 2006; 97: 582-8.
7. Ruan H, Wang J, Hu L, et al. Killing of brain tumor cells by hypoxia-responsive element mediated expression of BAX. Neoplasia 1999; 1: 431-7.
8. Ozawa T, Hu JL, Hu LJ, et al. Functionality of hypoxia-induced BAX expression in a human glioblastoma xenograft model. Cancer Gene Ther 2005; 12: 449-55.
9. Carmeliet P, Dor Y, Herbert JM, et al. Role of HIF-1alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis. Nature 1998; 394: 485-90.
10. Vleugel MM, Greijer AE, Shvarts A, et al. Differential prognostic impact of hypoxia induced and diffuse HIF-1alpha expression in invasive breast cancer. J Clin Pathol 2005; 58: 172-7.
11. Yoshimura H, Dhar DK, Kohno H, et al. Prognostic impact of hypoxia-inducible factors 1alpha and 2alpha in colorectal cancer patients: correlation with tumor angiogenesis and cyclooxygenase-2 expression. Clin Cancer Res 2004; 10: 8554-60.
12. Ogura E, Senzaki H, Yamamoto D, et al. Prognostic significance of Bcl-2, Bcl-xL/S, Bax and Bak expressions in colorectal carcinomas. Oncol Rep 1999; 6: 365-9.
13. Schelwies K, Sturm I, Grabowski P, et al. Analysis of P53/BAX in primary colorectal carcinoma: low BAX protein expression is a negative prognostic factor in UICC stage III tumors. Int J Cancer 2002; 99: 589-96.
14. Nehls O, Okech T, Hsieh CJ, et al. Low BAX protein expression correlates with disease recurrence in preoperatively irradiated rectal carcinoma. Int J Radiat Oncol Biol Phys 2005; 61: 85-91.
15. Kress S, Stein A, Maurer P, et al. Expression of hypoxia-inducible genes in tumor cells. J Cancer Res Clin Oncol 1998; 124: 315-20.
16. Famulski W, Sulkowska M, Wincewicz A, et al. P53 correlates positively with VEGF in preoperative sera of colorectal cancer patients. Neoplasma 2006; 53: 43-8.
17. Koukourakis MI, Giatromanolaki A, Harris AL, et al. Comparison of metabolic pathways between cancer cells and stromal cells in colorectal carcinomas: a metabolic survival role for tumor-associated stroma. Cancer Res 2006; 66: 632-7.
18. Hansson LO, Friedler A, Freund S, et al. Two sequence motifs from HIF-1alpha bind to the DNA-binding site of P53. Proc Natl Acad Sci USA 2002; 99: 10305-9.
19. Chen D, Li M, Luo J, et al. Direct interactions between HIF-1 alpha and Mdm2 modulate P53 function. J Biol Chem 2003; 278: 13595-8.
20. An WG, Kanekal M, Simon MC, et al. Stabilization of wild-type P53 by hypoxia-inducible factor 1alpha. Nature 1998; 392: 405-8.
21. Liu J, Shibata T, Qu R, et al. Influences of the P53 status on hypoxia-induced gene expression. J Radiat Res 2004; 45: 333-9.
22. Vleugel MM, Shvarts D, van der Wall E, van Diest PJ. p300 and P53 levels determine activation of HIF-1 downstream targets in invasive breast cancer. Hum Pathol 2006; 37: 1085-92.
23. Wang J, Biju MP, Wang MH, et al. Cytoprotective effects of hypoxia against cisplatin-induced tubular cell apoptosis: involvement of mitochondrial inhibition and P53 suppression. J Am Soc Nephrol 2006; 17: 1875-85.
24. Erler JT, Cawthorne CJ, Williams KJ, et al. Hypoxia-mediated down-regulation of Bid and Bax in tumors occurs via hypoxia-inducible factor 1-dependent and -independent mechanisms and contributes to drug resistance. Mol Cell Biol 2004; 24: 2875-89.
25. Sasabe E, Tatemoto Y, Li D, et al. Mechanism of HIF-1alpha-dependent suppression of hypoxia-induced apoptosis in squamous cell carcinoma cells. Cancer Sci 2005; 96: 394-402.
26. Wang Y, Pakunlu RI, Tsao W, et al. Bimodal effect of hypoxia in cancer: role of hypoxia inducible factor in apoptosis. Mol Pharm 2004; 1: 156-65.
27. Teraishi F, Wu S, Inoue S, et al. Antitumor activity and down-regulation of pro-angiogenic molecules in human prostate cancer cells by a novel thiazolidione compound. Prostate 2006; 66: 430-8.
28. Sivridis E, Giatromanolaki A, Koukourakis MI. Proliferating fibroblasts at the invading tumour edge of colorectal adenocarcinomas are associated with endogenous markers of hypoxia, acidity, and oxidative stress. J Clin Pathol 2005; 58: 1033-8.
29. Yoo YG, Yeo MG, Kim DK, Park H, Lee MO. Novel function of orphan nuclear receptor Nur77 in stabilizing hypoxia-inducible factor-1alpha. J Biol Chem 2004; 279: 53365-73.
30. Chao DT, Linette GP, Boise LH, et al. Bcl-xL and Bcl-2 repress a common pathway of cell death. J Exp Med 1995; 182: 821-8.
31. Hattori T, Ookawa N, Fujita R, et al. Heterodimerization of Bcl-2 and Bcl-X(L) with Bax and Bad in colorectal cancer. Acta Oncol 2000; 39: 495-500.
32. Kanczuga-Koda L, Sulkowski S, Koda M, et al. Connexin 26 correlates with Bcl-xL and Bax proteins expression in colorectal cancer. World J Gastroenterol 2005; 11: 1544-8.